Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate

Biomaterials

Volumn 32, Issue 3, 2011, Pages 933-941

  Lopez, Renata F V ^a   Seto, Jennifer E ^a   Blankschtein, Daniel ^a   Langer, Robert ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Confocal fluorescence microscopy; Inductively coupled plasma mass spectrometry; Low frequency sonophoresis; Quantum dots; Skin permeability enhancer; Transdermal penetration pathways

Indexed keywords

CONFOCAL FLUORESCENCE MICROSCOPY; LOW FREQUENCY; QUANTUM DOT; SKIN PERMEABILITY ENHANCER; TRANSDERMAL;

CONFOCAL MICROSCOPY; CONTROLLED DRUG DELIVERY; DYES; ELECTROMAGNETIC INDUCTION; FLUORESCENCE; FLUORESCENCE MICROSCOPY; INDUCTIVELY COUPLED PLASMA; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; NANOPARTICLES; SODIUM SULFATE; SPECTROMETRY; ULTRASONICS;

SEMICONDUCTOR QUANTUM DOTS;

DODECYL SULFATE SODIUM; NANOPARTICLE; QUANTUM DOT;

ANIMAL TISSUE; ARTICLE; DERMIS; DRUG DELIVERY SYSTEM; HYDRODYNAMICS; NONHUMAN; PASSIVE TRANSPORT; PRIORITY JOURNAL; SKIN PENETRATION; SWINE; ULTRASOUND; ZETA POTENTIAL;

ANIMALS; DRUG CARRIERS; MASS SPECTROMETRY; MICROSCOPY, CONFOCAL; NANOPARTICLES; QUANTUM DOTS; SKIN; SODIUM DODECYL SULFATE; ULTRASONICS;

SUIDAE;

EID: 78549249985     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.09.060     Document Type: Article

References (31)

1. Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?. J Pharm Sci 2010, 99(1):21-50.
2. Cevc G., Vierl U. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release 2010, 141(3):277-299.
3. Patlolla R.R., Desai P.R., Belay K., Singh M.S. Translocation of cell penetrating peptide engrafted nanoparticles across skin layers. Biomaterials 2010, 31(21):5598-5607.
4. Lee P.W., Hsu S.H., Tsai J.S., Chen F.R., Huang P.J., Ke C.J., et al. Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking. Biomaterials 2010, 31(8):2425-2434.
5. Kuo T.R., Wu C.L., Hsu C.T., Lo W., Chiang S.J., Lin S.J., et al. Chemical enhancer induced changes in the mechanisms of transdermal delivery of zinc oxide nanoparticles. Biomaterials 2009, 30(16):3002-3008.
6. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol 2007, 127:143-153.
7. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 2006, 91(1):159-165.
8. Zhang L.W., Yu W.W., Colvin V.L., Monteiro-Riviere N.A. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol 2008, 228(2):200-211.
9. Wu X., Landfester K., Musyanovych A., Guy R.H. Disposition of charged nanoparticles after their topical application to the skin. Skin Pharmacol Physiol 2010, 23(3):117-123.
10. Park K. Nano is better than micro for targeted vaccine delivery. J Control Release 2010, 144(2):117.
11. Wu X., Price G.J., Guy R.H. Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin. Mol Pharmacol 2009, 6(5):1441-1448.
12. Baroli B., Ennas M.G., Loffredo F., Isola M., Pinna R., Lopez-Quintela M.A. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 2007, 127(7):1701-1712.
13. Gupta J., Prausnitz M.R. Recovery of skin barrier properties after sonication in human subjects. Ultrasound Med Biol 2009, 35(8):1405-1408.
14. Ogura M., Paliwal S., Mitragotri S. Low-frequency sonophoresis: current status and future prospects. Adv Drug Deliv Rev 2008, 60(10):1218-1223.
15. Seto J.E., Polat B.E., Lopez R.F.V., Blankschtein D., Langer R. Effects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: comparative in vitro studies with full-thickness and split-thickness pig and human skin. J Control Release 2010, 145(1):26-32.
16. Matousek J.L., Campbell K.L. A comparative review of cutaneous pH. Vet Dermatol 2002, 13(6):293-300.
17. Farinha A., Kellogg S., Dickinson K., Davison T. Skin impedance reduction for electrophysiology measurements using ultrasonic skin permeation: initial report and comparison to current methods. Biomed Instrum Technol 2006, 40(1):72-77.
18. Kushner J., Blankschtein D., Langer R. Heterogeneity in skin treated with low-frequency ultrasound. J Pharm Sci 2008, 97(10):4119-4128.
19. Pendlington R.U. In vitro percutaneous absorption measurements. Principles and practice of skin toxicology 2008, 129-148. John Wiley & Sons Ltd., England. R.P. Chilcott, S. Price (Eds.).
20. Alvarez-Román R., Naik A., Kalia Y.N., Guy R.H., Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release 2004, 99(1):53-62.
21. Polat BE, Seto JE, Blankschtein D, Langer R. Application of the aqueous porous pathway model to quantify the effect of sodium lauryl sulfate on ultrasound-induced skin structural perturbation. J Pharm Sci, in press, doi:10.1002/jps.22361.
22. Paliwal S., Menon G.K., Mitragotri S. Low-frequency sonophoresis: ultrastructural basis for stratum corneum permeability assessed using quantum dots. J Invest Dermatol 2006, 126(5):1095-1101.
23. Monteiro-Riviere N.A., Baroli B. Nanomaterial penetration. Toxicology of the skin 2010, 333-346. Informa Healthcare, New York. N.A. Monteiro-Riviere (Ed.).
24. Roberts M.S., Walker M. Water: the most natural penetration enhancer. Pharmaceutical skin penetration enhancement 1993, 1-30. Marcel Dekker, Inc., New York. K.A. Walters, J. Hadgraft (Eds.).
25. Bronaugh R.L. Methods for in vitro percutaneous absorption. Marzulli and Maibach's dermatotoxicology 2007, 307-310. CRC Press, Florida. 7th ed. H. Zhai, K.-P. Wilhelm, H.I. Maibach (Eds.).
26. Polat BE, Figueroa PL, Blankschtein D, Langer R. Transport pathways and enhancement mechanisms within localized and non-localized transport regions in skin treated with low-frequency sonophoresis and sodium lauryl sulfate. J Pharm Sci, in press, doi:10.1002/jps.22280.
27. Tezel A., Sens A., Mitragotri S. A theoretical analysis of low-frequency sonophoresis: dependence of transdermal transport pathways on frequency and energy density. Pharm Res 2002, 19(12):1841-1846.
28. Dechadilok P., Deen W.M. Electrostatic and electrokinetic effects on hindered convection in pores. J Colloid Interface Sci 2009, 338(1):135-144.
29. Tezel A., Paliwal S., Shen Z., Mitragotri S. Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine 2005, 23(29):3800-3807.
30. Dahlan A., Alpar H.O., Stickings P., Sesardic D., Murdan S. Transcutaneous immunisation assisted by low-frequency ultrasound. Int J Pharm 2009, 368(1-2):123-128.
31. Paliwal S., Mitragotri S. Therapeutic opportunities in biological responses of ultrasound. Ultrasonics 2008, 48(4):271-278.